Physician profile
Evans C Bailey
NPI 1154448652
$1,382.38
in general payments reported to CMS, 2019-2025
11 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.84 · 2020: $127 · 2021: $304 · 2022: $374 · 2023: $205 · 2024: $239 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.58 | 2021-2024 | Rinvoq |
| Novartis Pharmaceuticals Corporation | $313.31 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $182.14 | 2020-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $170.91 | 2021-2023 | |
| Amgen INC. | $123.39 | 2020-2025 | Otezla, Otezla |
| Leo Pharma INC. | $80.61 | 2022-2024 | Adbry |
| Lilly USA, LLC | $53.36 | 2020-2023 | Taltz |
| Genentech USA, INC. | $45.97 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $38.31 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $33.10 | 2024 | |
| Verrica Pharmaceuticals INC. | $20.70 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evans Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.